rosacea
ROSACEA
Rosacea is a chronic cutaneous disease of the convexities of the central face (cheeks, chin, nose and central forehead) w/ periorbital and perioral skin sparing. This condition is attributed to chronic vasodilation.
Remissions and exacerbations are common.
It typically appears after 30 years of age but may occur at any age.  It commonly affects fair-skinned individuals.
The common presenting symptoms are facial flushing, stinging/burning erythema, telangiectasia, edema, papules, pustules, ocular lesions, and hypertrophy of the sebaceous glands of the nose with fibrosis.
A history of episodic flushing often heralds onset of rosacea.

Rosacea Patient Education

Patient Education

  • Patient should be informed that there is no cure for rosacea and that the available treatment options can only delay the progression of symptoms
  • The most important steps are to avoid precipitating and aggravating factors
  • Educate on the regular use of sunscreens, proper skin care, and importance of follow-up for ocular symptoms
    • Patients with ocular features should use ultraviolet-coated sunglasses and practice lid hygiene which includes warm compresses, dilute baby shampoo scrubs, application of lubricating eyedrops and meibomian gland expression
  • Consider a referral to:
    • A dermatologist if symptoms are more severe and acne are refractory to treatment
    • An ophthalmologist if patients with ocular rosacea have persistent or serious ocular symptoms
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 4 days ago
The novel coronavirus disease (COVID-19) pandemic appears to have a significant impact on oncological care, according to a study, which stresses the need for psycho-oncological support for cancer patients.
01 Aug 2020
Supplementation with probiotics may have positive effects in patients with type 2 diabetes mellitus (T2DM), reports a recent meta-analysis.
Roshini Claire Anthony, 30 Jul 2020

Frailty may indicate an increased risk of death from COVID-19, results of the COPE* study showed.

6 days ago
Treatment with tradipitant in patients with idiopathic or diabetic gastroparesis produces meaningful improvements in nausea and vomiting, according to the results of a phase II trial.